vs

Side-by-side financial comparison of INTERNATIONAL BANCSHARES CORP (IBOC) and OMNICELL, INC. (OMCL). Click either name above to swap in a different company.

OMNICELL, INC. is the larger business by last-quarter revenue ($309.9M vs $217.7M, roughly 1.4× INTERNATIONAL BANCSHARES CORP). INTERNATIONAL BANCSHARES CORP runs the higher net margin — 62.3% vs 3.7%, a 58.7% gap on every dollar of revenue. On growth, OMNICELL, INC. posted the faster year-over-year revenue change (14.9% vs 4.5%). INTERNATIONAL BANCSHARES CORP produced more free cash flow last quarter ($472.9M vs $38.6M). Over the past eight quarters, OMNICELL, INC.'s revenue compounded faster (5.8% CAGR vs 2.8%).

International Bancshares Corporation is a bank holding company based in Laredo, Texas whose primary subsidiary is International Bank of Commerce. Through its bank subsidiaries, it has 217 banking offices and 315 automated teller machines serving 88 communities in the U.S. states of Texas and Oklahoma.

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

IBOC vs OMCL — Head-to-Head

Bigger by revenue
OMCL
OMCL
1.4× larger
OMCL
$309.9M
$217.7M
IBOC
Growing faster (revenue YoY)
OMCL
OMCL
+10.4% gap
OMCL
14.9%
4.5%
IBOC
Higher net margin
IBOC
IBOC
58.7% more per $
IBOC
62.3%
3.7%
OMCL
More free cash flow
IBOC
IBOC
$434.3M more FCF
IBOC
$472.9M
$38.6M
OMCL
Faster 2-yr revenue CAGR
OMCL
OMCL
Annualised
OMCL
5.8%
2.8%
IBOC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IBOC
IBOC
OMCL
OMCL
Revenue
$217.7M
$309.9M
Net Profit
$106.9M
$11.4M
Gross Margin
45.3%
Operating Margin
62.8%
Net Margin
62.3%
3.7%
Revenue YoY
4.5%
14.9%
Net Profit YoY
-7.1%
261.7%
EPS (diluted)
$1.71
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBOC
IBOC
OMCL
OMCL
Q1 26
$309.9M
Q4 25
$217.7M
$314.0M
Q3 25
$218.1M
$310.6M
Q2 25
$208.2M
$290.6M
Q1 25
$198.2M
$269.7M
Q4 24
$208.3M
$306.9M
Q3 24
$211.8M
$282.4M
Q2 24
$207.8M
$276.8M
Net Profit
IBOC
IBOC
OMCL
OMCL
Q1 26
$11.4M
Q4 25
$106.9M
Q3 25
$108.4M
$5.5M
Q2 25
$100.1M
$5.6M
Q1 25
$96.9M
$-7.0M
Q4 24
$115.1M
Q3 24
$99.8M
$8.6M
Q2 24
$97.0M
$3.7M
Gross Margin
IBOC
IBOC
OMCL
OMCL
Q1 26
45.3%
Q4 25
41.5%
Q3 25
43.3%
Q2 25
43.9%
Q1 25
41.1%
Q4 24
46.2%
Q3 24
43.3%
Q2 24
41.3%
Operating Margin
IBOC
IBOC
OMCL
OMCL
Q1 26
Q4 25
62.8%
0.1%
Q3 25
62.6%
2.7%
Q2 25
60.5%
2.8%
Q1 25
61.1%
-4.3%
Q4 24
64.2%
4.0%
Q3 24
60.0%
2.3%
Q2 24
60.1%
1.2%
Net Margin
IBOC
IBOC
OMCL
OMCL
Q1 26
3.7%
Q4 25
62.3%
Q3 25
49.7%
1.8%
Q2 25
48.1%
1.9%
Q1 25
48.9%
-2.6%
Q4 24
71.5%
Q3 24
47.1%
3.1%
Q2 24
46.7%
1.3%
EPS (diluted)
IBOC
IBOC
OMCL
OMCL
Q1 26
$0.25
Q4 25
$1.71
$-0.05
Q3 25
$1.74
$0.12
Q2 25
$1.61
$0.12
Q1 25
$1.56
$-0.15
Q4 24
$1.85
$0.34
Q3 24
$1.60
$0.19
Q2 24
$1.56
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBOC
IBOC
OMCL
OMCL
Cash + ST InvestmentsLiquidity on hand
$5.5B
$239.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$3.3B
$1.3B
Total Assets
$16.6B
$2.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBOC
IBOC
OMCL
OMCL
Q1 26
$239.2M
Q4 25
$5.5B
$196.5M
Q3 25
$5.6B
$180.1M
Q2 25
$5.8B
$399.0M
Q1 25
$5.6B
$386.8M
Q4 24
$5.4B
$369.2M
Q3 24
$5.8B
$570.6M
Q2 24
$5.7B
$556.8M
Stockholders' Equity
IBOC
IBOC
OMCL
OMCL
Q1 26
$1.3B
Q4 25
$3.3B
$1.2B
Q3 25
$3.1B
$1.2B
Q2 25
$3.0B
$1.3B
Q1 25
$2.9B
$1.3B
Q4 24
$2.8B
$1.2B
Q3 24
$2.7B
$1.2B
Q2 24
$2.6B
$1.2B
Total Assets
IBOC
IBOC
OMCL
OMCL
Q1 26
$2.0B
Q4 25
$16.6B
$2.0B
Q3 25
$16.6B
$1.9B
Q2 25
$16.5B
$2.1B
Q1 25
$16.3B
$2.2B
Q4 24
$15.7B
$2.1B
Q3 24
$15.9B
$2.3B
Q2 24
$15.5B
$2.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBOC
IBOC
OMCL
OMCL
Operating Cash FlowLast quarter
$491.1M
$54.5M
Free Cash FlowOCF − Capex
$472.9M
$38.6M
FCF MarginFCF / Revenue
217.2%
12.5%
Capex IntensityCapex / Revenue
8.3%
Cash ConversionOCF / Net Profit
4.59×
4.80×
TTM Free Cash FlowTrailing 4 quarters
$809.9M
$110.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBOC
IBOC
OMCL
OMCL
Q1 26
$54.5M
Q4 25
$491.1M
$30.4M
Q3 25
$115.2M
$28.3M
Q2 25
$95.5M
$42.8M
Q1 25
$140.5M
$25.9M
Q4 24
$473.9M
$56.3M
Q3 24
$116.5M
$22.8M
Q2 24
$107.2M
$58.7M
Free Cash Flow
IBOC
IBOC
OMCL
OMCL
Q1 26
$38.6M
Q4 25
$472.9M
$22.6M
Q3 25
$112.2M
$18.5M
Q2 25
$91.6M
$31.0M
Q1 25
$133.1M
$14.8M
Q4 24
$459.8M
$47.2M
Q3 24
$109.6M
$13.9M
Q2 24
$104.9M
$49.1M
FCF Margin
IBOC
IBOC
OMCL
OMCL
Q1 26
12.5%
Q4 25
217.2%
7.2%
Q3 25
51.5%
6.0%
Q2 25
44.0%
10.7%
Q1 25
67.1%
5.5%
Q4 24
220.8%
15.4%
Q3 24
51.7%
4.9%
Q2 24
50.5%
17.8%
Capex Intensity
IBOC
IBOC
OMCL
OMCL
Q1 26
Q4 25
8.3%
2.5%
Q3 25
1.3%
3.1%
Q2 25
1.9%
4.1%
Q1 25
3.7%
4.1%
Q4 24
6.8%
3.0%
Q3 24
3.3%
3.1%
Q2 24
1.1%
3.5%
Cash Conversion
IBOC
IBOC
OMCL
OMCL
Q1 26
4.80×
Q4 25
4.59×
Q3 25
1.06×
5.18×
Q2 25
0.95×
7.58×
Q1 25
1.45×
Q4 24
4.12×
Q3 24
1.17×
2.64×
Q2 24
1.11×
15.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IBOC
IBOC

Segment breakdown not available.

OMCL
OMCL

Product revenues$174.8M56%
Service revenues$135.1M44%

Related Comparisons